Skip to main content

Table 2 Adequate clinical and parasitological response (ACPR) at day 28 (per-protocol population)

From: Efficacy and safety of fixed dose combination of arterolane maleate and piperaquine phosphate dispersible tablets in paediatric patients with acute uncomplicated Plasmodium falciparum malaria: a phase II, multicentric, open-label study

  n Success, n (%) 95 % CI
Age group 1 (6 months to <2 years) 19 19 (100.0) 82.35, 100.0
Age group 2 (2 to <6 years) 42 42 (100.0) 91.59, 100.0
Age group 3 (6 to ≤12 years) 65 65 (100.0) 94.48, 100.0
Overall age (6 months to ≤12 years) 126 126 (100.0) 97.11, 100.0